Dermatitis [clinicaltrials_resource:f3898163355388a4d9c3a8a19b300964]
Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers [clinicaltrials:NCT00001150]Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles [clinicaltrials:NCT00005781]Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients [clinicaltrials:NCT00176956]Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases. [clinicaltrials:NCT00217009]clinicaltrials:NCT00375713Olive Oil With Omega 3 to Treat Stasis Dermatitis [clinicaltrials:NCT00421161]clinicaltrials:NCT00667056A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM) [clinicaltrials:NCT00746382]Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma [clinicaltrials:NCT00748319]Salmon in Pregnancy Study [clinicaltrials:NCT00801502]clinicaltrials:NCT00868036Topical Application of Sulforaphane-containing Broccoli Sprout Extracts on Radiation Dermatitis [clinicaltrials:NCT00894712]A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema [clinicaltrials:NCT01012453]Efficacy and Safety of the Association of Dexamethasone 0.5 mg + Clemastine Fumarate 1 mg When Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis [clinicaltrials:NCT01125761]Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis [clinicaltrials:NCT01239719]Sequential Ascending Dose Study to Assess the Safety and Tolerability of REGN668 (SAR231893) in Patients With Atopic Dermatitis [clinicaltrials:NCT01259323]Barrier Film vs. Standard Skin Care in Preventing Dermatitis in Women With Breast Cancer Receiving Radiation [clinicaltrials:NCT01762020]Evaluation of Irritancy/Allergic Sensitivity to Natural Personal-care Products by Patch Tests [clinicaltrials:NCT01816542]A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis [clinicaltrials:NCT01840605]Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD) [clinicaltrials:NCT01910662]clinicaltrials:NCT01916980ADRN Barrier/Immunoprofiling Exploratory Pilot Study [clinicaltrials:NCT02115399]Phase 1 Study of Levocetirizine [clinicaltrials:NCT02447393]Drug Utilization Study on the Prescribing Indications for Cyproterone Acetate and Ethinyl Estradiol in 5 European Countries [clinicaltrials:NCT02494297]
condition [clinicaltrials_vocabulary:condition]
Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals [clinicaltrials:NCT00001760]Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles [clinicaltrials:NCT00005781]Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema) [clinicaltrials:NCT00076375]Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis [clinicaltrials:NCT00098150]clinicaltrials:NCT00106496Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis [clinicaltrials:NCT00117377]clinicaltrials:NCT00119158clinicaltrials:NCT00120523Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients [clinicaltrials:NCT00121316]Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis [clinicaltrials:NCT00121381]Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis [clinicaltrials:NCT00124436]Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis [clinicaltrials:NCT00124475]clinicaltrials:NCT00124709Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis [clinicaltrials:NCT00125333]Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions [clinicaltrials:NCT00129415]Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis [clinicaltrials:NCT00130364]Clinical Evaluation of Bacitracin [clinicaltrials:NCT00132600]Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate [clinicaltrials:NCT00133341]Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects [clinicaltrials:NCT00139581]Efalizumab for Eczema [clinicaltrials:NCT00146003]Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis [clinicaltrials:NCT00148746]Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis [clinicaltrials:NCT00150059]Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM) [clinicaltrials:NCT00152464]Psychiatric Problems in Chronic Skin Diseases [clinicaltrials:NCT00167752]Common Allergens in Skin Tests for Adult Atopic Dermatitis [clinicaltrials:NCT00173498]Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients [clinicaltrials:NCT00176956]clinicaltrials:NCT00179959Elidel-Study: Elidel in Patients With Atopic Dermatitis [clinicaltrials:NCT00180141]Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis [clinicaltrials:NCT00185510]Azathioprine Versus Corticosteroids in Parthenium Dermatitis [clinicaltrials:NCT00189397]Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic Dermatitis [clinicaltrials:NCT00224432]Efalizumab for Moderate to Severe Atopic Dermatitis [clinicaltrials:NCT00226057]Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand Dermatitis [clinicaltrials:NCT00226707]Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis [clinicaltrials:NCT00231998]Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis [clinicaltrials:NCT00232011]Long-term Study of Ciclosporin for Atopic Dermatitis [clinicaltrials:NCT00232063]Verification Study of Ciclosporin for Atopic Dermatitis [clinicaltrials:NCT00232076]Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis [clinicaltrials:NCT00232115]Short Term Growth in Children With Atopic Dermatitis [clinicaltrials:NCT00236106]Study Of Atopic Dermatitis In Pediatrics [clinicaltrials:NCT00257569]
condition browse [clinicaltrials_vocabulary:condition-browse]
Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals [clinicaltrials:NCT00001760]Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles [clinicaltrials:NCT00005781]Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema) [clinicaltrials:NCT00076375]Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis [clinicaltrials:NCT00098150]clinicaltrials:NCT00106496Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis [clinicaltrials:NCT00117377]clinicaltrials:NCT00119158clinicaltrials:NCT00120523Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients [clinicaltrials:NCT00121316]Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis [clinicaltrials:NCT00121381]Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis [clinicaltrials:NCT00124436]Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis [clinicaltrials:NCT00124475]clinicaltrials:NCT00124709Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis [clinicaltrials:NCT00125333]Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions [clinicaltrials:NCT00129415]Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis [clinicaltrials:NCT00130364]Clinical Evaluation of Bacitracin [clinicaltrials:NCT00132600]Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate [clinicaltrials:NCT00133341]Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects [clinicaltrials:NCT00139581]Efalizumab for Eczema [clinicaltrials:NCT00146003]Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis [clinicaltrials:NCT00148746]Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis [clinicaltrials:NCT00150059]Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM) [clinicaltrials:NCT00152464]Psychiatric Problems in Chronic Skin Diseases [clinicaltrials:NCT00167752]Common Allergens in Skin Tests for Adult Atopic Dermatitis [clinicaltrials:NCT00173498]Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients [clinicaltrials:NCT00176956]clinicaltrials:NCT00179959Elidel-Study: Elidel in Patients With Atopic Dermatitis [clinicaltrials:NCT00180141]Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis [clinicaltrials:NCT00185510]Azathioprine Versus Corticosteroids in Parthenium Dermatitis [clinicaltrials:NCT00189397]Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic Dermatitis [clinicaltrials:NCT00224432]Efalizumab for Moderate to Severe Atopic Dermatitis [clinicaltrials:NCT00226057]Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand Dermatitis [clinicaltrials:NCT00226707]Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis [clinicaltrials:NCT00231998]Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis [clinicaltrials:NCT00232011]Long-term Study of Ciclosporin for Atopic Dermatitis [clinicaltrials:NCT00232063]Verification Study of Ciclosporin for Atopic Dermatitis [clinicaltrials:NCT00232076]Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis [clinicaltrials:NCT00232115]Short Term Growth in Children With Atopic Dermatitis [clinicaltrials:NCT00236106]Study Of Atopic Dermatitis In Pediatrics [clinicaltrials:NCT00257569]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Dermatitis [clinicaltrials_resource:f3898163355388a4d9c3a8a19b300964]
Bio2RDF identifier
f3898163355388a4d9c3a8a19b300964
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f3898163355388a4d9c3a8a19b300964
identifier
clinicaltrials_resource:f3898163355388a4d9c3a8a19b300964
title
Dermatitis
@en
type
label
Dermatitis [clinicaltrials_resource:f3898163355388a4d9c3a8a19b300964]
@en
Dermatitis